BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 22795494)

  • 1. Comparison of diffusion-weighted MRI with 18F-fluorodeoxyglucose-positron emission tomography/CT and electroencephalography in sporadic Creutzfeldt-Jakob disease.
    Xing XW; Zhang JT; Zhu F; Ma L; Yin DY; Jia WQ; Huang XS; Pu CQ; Lang SY; Yu SY
    J Clin Neurosci; 2012 Oct; 19(10):1354-7. PubMed ID: 22795494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical diagnosis of MM2-type sporadic Creutzfeldt-Jakob disease.
    Hamaguchi T; Kitamoto T; Sato T; Mizusawa H; Nakamura Y; Noguchi M; Furukawa Y; Ishida C; Kuji I; Mitani K; Murayama S; Kohriyama T; Katayama S; Yamashita M; Yamamoto T; Udaka F; Kawakami A; Ihara Y; Nishinaka T; Kuroda S; Suzuki N; Shiga Y; Arai H; Maruyama M; Yamada M
    Neurology; 2005 Feb; 64(4):643-8. PubMed ID: 15728285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose metabolism in nine patients with probable sporadic Creutzfeldt-Jakob disease: FDG-PET study using SPM and individual patient analysis.
    Renard D; Vandenberghe R; Collombier L; Kotzki PO; Pouget JP; Boudousq V
    J Neurol; 2013 Dec; 260(12):3055-64. PubMed ID: 24068371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography with [(18)F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD).
    Henkel K; Zerr I; Hertel A; Gratz KF; Schröter A; Tschampa HJ; Bihl H; Büll U; Grünwald F; Drzezga A; Spitz J; Poser S
    J Neurol; 2002 Jun; 249(6):699-705. PubMed ID: 12111302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of staging and early response to chemotherapy with whole-body diffusion-weighted MRI in malignant lymphoma patients: A comparison with FDG-PET/CT.
    Tsuji K; Kishi S; Tsuchida T; Yamauchi T; Ikegaya S; Urasaki Y; Fujiwara Y; Ueda T; Okazawa H; Kimura H
    J Magn Reson Imaging; 2015 Jun; 41(6):1601-7. PubMed ID: 25111444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
    Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
    Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose metabolism in sporadic Creutzfeldt-Jakob disease: a statistical parametric mapping analysis of (18) F-FDG PET.
    Kim EJ; Cho SS; Jeong BH; Kim YS; Seo SW; Na DL; Geschwind MD; Jeong Y
    Eur J Neurol; 2012 Mar; 19(3):488-93. PubMed ID: 22050286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI sequence findings in sporadic Creutzfeldt-Jakob disease.
    Tian HJ; Zhang JT; Lang SY; Wang XQ
    J Clin Neurosci; 2010 Nov; 17(11):1378-80. PubMed ID: 20727770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of diffusion-weighted MRI and 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for detecting primary colorectal cancer and regional lymph node metastases.
    Ono K; Ochiai R; Yoshida T; Kitagawa M; Omagari J; Kobayashi H; Yamashita Y
    J Magn Reson Imaging; 2009 Feb; 29(2):336-40. PubMed ID: 19161185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A correlative study of FDG PET, MRI/CT, electroencephalography, and clinical features in subacute sclerosing panencephalitis.
    Yilmaz K; Yilmaz M; Mete A; Celen Z
    Clin Nucl Med; 2010 Sep; 35(9):675-81. PubMed ID: 20706040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging the early response to chemotherapy in advanced lung cancer with diffusion-weighted magnetic resonance imaging compared to fluorine-18 fluorodeoxyglucose positron emission tomography and computed tomography.
    Tsuchida T; Morikawa M; Demura Y; Umeda Y; Okazawa H; Kimura H
    J Magn Reson Imaging; 2013 Jul; 38(1):80-8. PubMed ID: 23239463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response evaluation after chemoradiotherapy for advanced nodal disease in head and neck cancer using diffusion-weighted MRI and 18F-FDG-PET-CT.
    Schouten CS; de Graaf P; Alberts FM; Hoekstra OS; Comans EF; Bloemena E; Witte BI; Sanchez E; Leemans CR; Castelijns JA; de Bree R
    Oral Oncol; 2015 May; 51(5):541-7. PubMed ID: 25725587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion-weighted MRI compared to FDG PET/CT for assessment of early treatment response in lymphoma.
    Hagtvedt T; Seierstad T; Lund KV; Løndalen AM; Bogsrud TV; Smith HJ; Geier OM; Holte H; Aaløkken TM
    Acta Radiol; 2015 Feb; 56(2):152-8. PubMed ID: 24585944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of FDG-PET/MRI and WB-DW-MRI in the evaluation of lymphoma: a prospective comparison to standard FDG-PET/CT.
    Herrmann K; Queiroz M; Huellner MW; de Galiza Barbosa F; Buck A; Schaefer N; Stolzman P; Veit-Haibach P
    BMC Cancer; 2015 Dec; 15():1002. PubMed ID: 26699124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-body MRI with diffusion-weighted imaging as an adjunct to
    Willemse JRJ; Lahaye MJ; Kok NFM; Grotenhuis BA; Aalbers AGJ; Beets GL; Rijsemus C; Maas M; van Golen LW; Beets-Tan RGH; Lambregts DMJ
    Colorectal Dis; 2024 Feb; 26(2):290-299. PubMed ID: 38145899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to chemotherapy in gastric adenocarcinoma with diffusion-weighted MRI and (18) F-FDG-PET/CT: correlation of apparent diffusion coefficient and partial volume corrected standardized uptake value with histological tumor regression grade.
    Giganti F; De Cobelli F; Canevari C; Orsenigo E; Gallivanone F; Esposito A; Castiglioni I; Ambrosi A; Albarello L; Mazza E; Gianolli L; Staudacher C; Del Maschio A
    J Magn Reson Imaging; 2014 Nov; 40(5):1147-57. PubMed ID: 24214734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is diffusion-weighted MRI superior to FDG-PET or FDG-PET/CT in evaluating and predicting pathological response to preoperative neoadjuvant therapy in patients with rectal cancer?
    Li YL; Wu LM; Chen XX; Delproposto Z; Hu JN; Xu JR
    J Dig Dis; 2014 Oct; 15(10):525-37. PubMed ID: 25060294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study.
    Klenk C; Gawande R; Uslu L; Khurana A; Qiu D; Quon A; Donig J; Rosenberg J; Luna-Fineman S; Moseley M; Daldrup-Link HE
    Lancet Oncol; 2014 Mar; 15(3):275-85. PubMed ID: 24559803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined findings of FDG-PET and arterial spin labeling in sporadic Creutzfeldt-Jakob disease.
    Yuan J; Wang S; Hu W
    Prion; 2018; 12(5-6):310-314. PubMed ID: 30223705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.